Literature DB >> 16580620

Policy implications of genetic testing: not just for geneticists anymore.

Gail H Javitt1.   

Abstract

Genetic testing is expanding rapidly to become part of mainstream medicine. While genetic tests bring with them the promise of improved diagnosis and treatment for patients, they also raise several policy challenges. These challenges include the lack of a coherent oversight system to ensure the quality of tests and testing laboratories, the rise of direct-to-consumer genetic testing, the dearth of professional guidelines to assist the transition of genetic tests from research to medical practice, and the absence of federal legislation to protect the privacy of genetic information and prevent genetic discrimination.

Entities:  

Mesh:

Year:  2006        PMID: 16580620     DOI: 10.1053/j.ackd.2006.01.003

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  6 in total

1.  Genetic counseling in the adult with congenital heart disease: what is the role?

Authors:  Luke Burchill; Steven Greenway; Candice K Silversides; Seema Mital
Journal:  Curr Cardiol Rep       Date:  2011-08       Impact factor: 2.931

2.  The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.

Authors:  S W Gray; R C Hornik; J S Schwartz; K Armstrong
Journal:  Clin Genet       Date:  2011-11-02       Impact factor: 4.438

3.  Community-based dialogue: engaging communities of color in the United states' genetics policy conversation.

Authors:  Vence L Bonham; Toby Citrin; Stephen M Modell; Tené Hamilton Franklin; Esther W B Bleicher; Leonard M Fleck
Journal:  J Health Polit Policy Law       Date:  2009-06       Impact factor: 2.265

4.  Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.

Authors:  Stacy W Gray; Cristin O'Grady; Lauren Karp; Daniel Smith; J Sanford Schwartz; Robert C Hornik; Katrina Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-24       Impact factor: 4.254

5.  Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.

Authors:  Sharon E Plon; H Paul Cooper; Bethany Parks; Shweta U Dhar; P Adam Kelly; Armin D Weinberg; Stephanie Staggs; Tao Wang; Susan Hilsenbeck
Journal:  Genet Med       Date:  2011-02       Impact factor: 8.822

6.  Perceptions of students in health and molecular life sciences regarding pharmacogenomics and personalized medicine.

Authors:  Lejla Mahmutovic; Betul Akcesme; Camil Durakovic; Faruk Berat Akcesme; Aida Maric; Muhamed Adilovic; Nour Hamad; Matthias Wjst; Oliver Feeney; Sabina Semiz
Journal:  Hum Genomics       Date:  2018-11-14       Impact factor: 4.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.